ArticleAnnals of joint2025
Plasma endothelin-1 levels in patients with rotator cuff tear: a case-control study.
Article in Annals of joint, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Several recent studies have demonstrated that the alteration of tendon microcirculation is one of the main causes of rotator cuff degeneration and tear. The aim of this study was to assess if patients with a rotator cuff tear (RCT) exhibit altered levels of endothelin-1 (ET-1), a powerful vasoconstrictor that could play a key role in the pathogenesis of RCTs, as well as in other tendon structures. Methods: A case-control study was conducted on 103 participants, divided into 60 cases and 43 controls. A sample of peripheral venous blood was collected from each participant. Each sample underwent centrifugation to obtain plasma, which was then analyzed using a specific enzyme-linked immunosorbent assay (ELISA) kit for human ET-1. Results: A total of 54 cases and 25 controls were recruited. Initially, we compared the mean plasma concentration of ET-1 of the two study groups. Although there is a higher mean value in controls compared to cases, the difference is not statistically significant (P>0.05). Subsequently, we compared the mean values of ET-1 based on the severity of the tear. Twenty-four patients had a small RCT, and their mean concentration of ET-1 was of 88.39 pg/mL, eight patients had a large tear and a mean ET-1 concentration of 72.07 pg/mL, while twenty-two patients showed a massive tear and a mean concentration of ET-1 of 78.27 pg/mL. However, this difference in ET-1 concentration was not statistically significant (P>0.05). Conclusions: From the preliminary results obtained, we can observe that, in terms of plasma ET-1 concentration, there are no statistically significant differences between cases with rotator cuff rupture and controls. Given the current limitations of the study, we expect to further expand the sample size to verify if these preliminary results will be confirmed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.